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1. Introduction 
Lymphoid tissue is a major target for glucocorti- 
coids. In liver, these hormones act through an induc- 
tion of enzymes mediated by the nuclear binding of a 
cytoplasmic receptor protein. In lymphocytes, gluco- 
corticoids inhibit cell proliferation and membrane 
transport processes, but the biochemical basis of these 
changes remains unknown (reviewed [ 11). In humans, 
circulating lymphocytes and permanent lines derived 
thereof provide an easily accessible source of cells for 
receptor studies [2,3]. The lymphoblastoid IM-9 cell 
line has been extensively used for investigating the 
insulin receptor [2]. Although IM-9 cells are not 
growthinhibited by glucocorticoids (unpublished) 
they are sensitive to these hormones. Cortisol was 
reported to increase the insulin-binding capacity of 
IM-9 cells [4], a finding confirmed in our laboratory. 
We report here that IM-9 cells do contain a typical 
glucocorticoid receptor but no receptor for other 
steroid hormones. In addition, we show that dexa- 
methasone, a synthetic glucocorticoid, stimulates 
specifically S’nucleotidase (5’-ribonucleotide phos- 
phohydrolase, EC 3.1.3.5), an enzyme associated 
with the plasma membrane in human lymphocytes 
[5], and that the stimulation is mediated by the gluco- 
corticoid receptor. 
2. Materials and methods 
All cell washings and homogenization, and centrif- 
ugation steps were at 0°C. 
2.1. Cell cultures 
IM-9 cells were grown at 37’C as spinner cultures 
ElsevierlNorth-Holland Biomedical Press 
(density up to 2.5 X lo6 cells/ml) in RPM1 medium 
containing 10% fetal calf serum, 50 units penicillin/ 
ml and 50 units streptomycin/ml (all from Gibco 
Bio-Cult, Paisley). In serum-free medium experiments, 
serum was replaced by an equal volume of 10 g/l 
bovine serum albumin solution in phosphate-buffered 
saline (PBS) containing 150 mM NaCl, 25 mM KCI, 
8 mM NaJIP04 .2 HzO, 1.5 mM KH2PO4 (pH 7.4). 
2.2. Binding studies 
For cell-free binding, cells were resuspended in 
serum-free medium for 45 min at 37’C, washed in 
PBS, and stored as pellets at -8O’C. The pellets were 
added with 20 mMN- [tris-(hydroxymethyl)methyl]- 
glycine (Tricine, Calbiochem, San Diego, CA), 10 mM 
Na*MoOa - 2 Hz0 (pH 7.4) (2.5 X 10’ cells/ml) and 
homogenized with the tight pestle of a Dounce 
homogenizer. The homogenates were centrifuged for 
20 min at 16 000 rev./min (Sorvall RC2-B centrifuge, 
rotor SS-34). The supernate was centrifuged for 60 min 
at 49 000 rev./min (Beckman L2-65B centrifuge, 
rotor 50Ti). Portions (0.1 ml) of the resulting super- 
nate (cytosol fraction) were incubated at 0°C in the 
presence of [3H]dexamethasone with or without 
12 PM nonradioactive dexamethasone, following 
which specific binding was determined by the char- 
coal assay [6]. 
Binding to intact cells was done as in [7] by incu- 
bating 4.8 X lo6 cells in 0.4 ml aliquots of serum-free 
medium in the presence of 1,2- [3H] dexamethasone 
(spec. radioact. 23 Ci/mmol, Radiochemical Centre, 
Amersham) at up to 100 nM. Parallel incubations con- 
tained in addition 12 PM unlabelled dexamethasone 
for determination of nonspecific binding. After equili- 
brium had been reached (3 h at 37’C) cells were washed 
3 times with 3.5 ml ice-cold PBS by centrifugation at 
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4000 rev./r& for 5 min in a Martin-Christ UJIS cen- 
trifuge. The pellet was resuspended in 0.7 ml 1.5 mM 
MgClz solution, lysed by freeze-thawing, and centri- 
fuged at 10 000 rev./min for 2 min in a Beckman 
microfuge B. Supernate-bound and particulate-bound 
steroid was determined by counting the radioactivity 
associated with the supernatant and the pellet frac- 
tions, respectively f8]. 
Cells were washed by centrifugation with Puck’s 
buffer containing 137 mM NaCl, 5.4 mM KCl, 4.2 mM 
NaHC03, 5 mM glucose (pH 7.45). The last pellets 
were kept frozen at -80°C. After thawing, pellets 
were homogenized either in a 0.1% (w/v) Triton X-I 00 
solution by 10 s-sonication at 60 W (Branson Sonifier), 
or in 0.25 M sucrose, 3 mM imidazole-HCl (pH 7.4) 
by 10-l 5 strokes of the tight-fitting pestle of a Dounce 
homogenizer. 5’-Nucleotidase was assayed at pH 7.5 
by two different methods based on the dete~nation 
of either the Pi forrne’d from adenosine 5’-monophos- 
phate disodium salt 191, or the radiolabelled adenine 
liberated from [2-3H]adenosine 5’-monophosphate, 
ammonium salt ([lo], under the conditions in [ 113). 
Incubations were for 60min at 37°C. Identical specific 
activities were obtained by both methods. The follow- 
ing constituents were assayed by published procedures: 
alkaline phosphodiesterase I @C 3.1.4.1), alkaline 
phosphatase (EC 3.1.3.1), glutamine synthetase (EC 
6.3.1.2), glucose 6-phosphatase (EC 3.1.3.9) [9], tyro- 
sine aminotransferase (EC 2.6.1.5) [ 121, nucleoside 
diphosphatase (EC 3.6.1) [13], protein [14]. 
3. Results and discussion 
3.1. ~denti~c~tion of the glu~ocort~coid receptor 
Cell-free binding experiments showed that the cyto- 
sol fraction from IM-9 cells contains a constituent that 
binds [3H]dexamethasone i  a saturable way, i.e., 
becomes undetectable in the presence of loo--1000. 
fold excess nonradioactive dexamethasone. The kinetic 
parameters of specific dexamethasone binding are 
given in table 1. The rate of association followed sec- 
ond-order kinetics. At 1 nM dexamethasone, equili- 
brium was reached after 18 h. Binding was completely 
reversible and dissociation was a first-order process 
with tllz - 8 h. The steroid concentration-dependence 
of equi~b~um binding yielded data compatible with a 
single class of noninteracting sites which bind dexa- 
methasone with high affinity (fig.1). The Hill coeffi- 
cient was 0.99 + 0.07 (SD). The equilibrium constant 
was similar to the ratio of rate constants (table 1). 
Specific binding of f3H] dexamethasone was 
i~bited when the cytosol fraction was pre~cubated 
with 50 gg/ml of either of trypsin, chymotrypsin, 
pronase, 6mM N-ethylmaleimide or 12 mM iodo- 
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Fig.1. Concentration-dependence of [3H]dexamethasone 
binding at eq~brium, in the cytosol fraction from IM-9 
cells. (0) Total; (A) nonspecific; (e) specific binding. Incuba- 
tions were for 20 h at 0°C. RS and S refer to specitkaBy- 
bound and free steroid, respectively. 
Table 1 
Kinetic parameters of [3H]de~met~sone binding to glucocorticoid receptor in the cytosol fraction from IM-9 cells 
k 
($I. min-I) 
koff kofflkon Kd R, (pmoll Sites/ 
(min-‘) (nM) (nM) mg protein) cell 
2.6 x lo5 1.5 x 10-s 5.8 5.0 f 1.5 1.23 i 0.45 23 000 
Mean + SD of 2 or 11 (gd, Ro) expt. at 0°C. k,, and koff refer to the rate constants determined from the time kinetics. krd and 
R, refer to the equiBbrium dissociation constant and concentration of receptor sites determined from Scatchard plots 
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acetamide, whereas 50 /.&ml DNase I or RNase I had 
no effect. Binding was abolished at pH <6.5 and >8.5 
or after heating the cytosol fraction at 45’C. 
In IM-9 cell cytosol fraction, a variety of nonradio- 
active steroids competitively inhibited [3H]dexametha- 
sone binding, in keeping with their affinity for the rat 
hepatic glucocorticoid receptor [ 1,6]. The order of 
potency was: 
dexamethasone > corticosterone > cortisol > 1 l/3- 
hydroxyprogesterone > 1 I-deoxycorticosterone > 
progesterone > 11 -deoxycortisol > aldosterone >
testosterone > estradiol. 
Cortisol had a rU, (40 nM) which is near the value of 
free circulating concentration of cortisol in man. 
Finally, upon incubation of intact cells with [3H]- 
dexamethasone at 37”C, -50% of the specifically 
bound steroid was found associated with the partic- 
ulate fraction, as is the case when ~ucoco~icoids are 
bound to the glucocorticoid receptor in intact lympho- 
cytes [ 1,8]. Thus, the kinetic, chemical and steric 
properties of the specific dexamethasone binding 
sites are consistent with their being borne by the gluco- 
corticoid receptor described in other cells [6,8]. 
An important point in view of using the IM-9 cell 
Iine as a model system for the human glucocorticoid 
receptor is to determine whether it contains receptors 
for any of the 4 other classes of steroid hormones as 
is the case of certain cloned cell lines [ 151. The cyto- 
sol fraction was incubated for 20 h with the 3H-labelled 
natural mineralocorticoid, progestogen, androgen or 
estrogen at a concentration 30-fold greater than the 
publishedXd-values fortheir respective receptor. There 
wasvery little specific binding of these steroids except 
progesterone (fig.2). In all cases, Scatchard analysis of 
results obtained at several steroid concentrations 
showed that the binding, extrapolated for infinite 
concentration of free steroid, corresponded to the 
concentration of sites defined with [3H]dexametha- 
sone. Thus, the binding of progesterone and of the sex 
steroids reflects their interaction with the glucocorti- 
coid receptor for which they are known ~tagonists 
[6]. It is concluded that IM-9 cells possess only one 
type of steroid receptor and which is specific for 
glucocorticoids. 
3.2. G~u~o~ortic~id*~ti~u~tion of 5’-nucleotidax 
activiiy 
We found that IM-9 cells contain a typical (Km, 
pH optimum, association with membranes) 5’-nucleo- 
tidase, an enzyme of pericellular membranes in several 
Fig-Z. Specific binding (RS) of the 3H-labell& steroid hor- 
mones to the cytosol fraction from M-9 cells. Incubations 
were at 0°C for 20 h in the presence of the indicated concen- 
trations (S) of free steroid. 
cell types [ 161 and in human lymphocytes [5]. When 
the cells were incubated with 0.5 m dex~e~asone 
for 48 h, 5’nucleotidase activity was stimulated -2.5- 
fold, from 4.6 + 0.7-l 1.3 f. 1.1 SD (n = 13) mU/mg 
protein. Results were identical whether the activity 
was determined by assaying the phosphate released or 
the Z3H]adenine produced from [3H]AMP. 
Several expe~ent~ results uggest that this effect 
of dexamethasone is mediated by the glucocorticoid 
receptor and not by a direct action of high steroid 
concentrations on the cell membrane. 
(i) The stimulation required >lO h exposure to the 
steroid to occur. This lag period is reminiscent 
of that of the ~ucocorticoid receptor-mediated 
stimulation in rat hepatoma cells of alkaline 
phosphodiesterase I [ 111, another plasma mem- 
brane enzyme [ 161 which is lacking in IM-9 
cells. 
(ii) 5Nucleotidase was stimulated by as little as 3 
nM dex~et~sone. The dose-response curve 
was superimposable to that of receptor occupancy 
by dexamethasone in intact cells at 37°C (fig.3). 
(iii) The effect of different steroids (10 MM, 48 h) 
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Fig.3. Concentration-dependence of dexamethasone binding 
and 5’.nucleotidase stimulation in intact IM-9 cells. Cultures 
were incubated at 37°C in serum-free medium, for 3 h with 
labeled (0) or for 48 h with unlabeled (A) dexamethasone. 
Specific binding ranged from 2800-11 200 dpm/aliquot. 
Nonspecific binding ranged from 285-1900 dpm/aliquot. 
Basal 5’.nucleotidase activity was 2.8 mU/mg protein. After 
maximal stimulation 5’.nucleotidase activity was 12 mU/mg 
protein. 
on 5’.nucleotidase of IM-9 cells corresponds to 
what is expected from their interaction with the 
glucocorticoid receptor of these cells and from 
their agonist or antagonist properties in other 
systems [ 1,6]. Normalised potencies were as 
follows: dexamethasone 100, corticosterone 88, 
1 l/I-hydroxyprogesterone 2 1, aldosterone 14, 
11 deoxycorticosterone, progesterone, 11 -deoxy- 
cortisol and dihydrotestosterone, 0. 
The stimulation of 5’.nucleotidase by glucocorti- 
coids is specific in that none of the following enzyme 
activities were altered following dexamethasone treat- 
ment (0.5 PM, 48 h) of IM-9 cells: tyrosine amino- 
transferase, glutamine synthetase, glucose 6.phospha- 
tase or a nonspecific phosphatase acting on glucose 
6.phosphate, nucleose (ADP)-diphosphatase and 
alkaline phosphatase. 
We have shown that cells from the permanent 
human lymphoblastoid IM-9 line possess a typical 
glucocorticoid receptor. A glucocorticoid response 
can be quantitatively measured which is the specific 
stimulation of the plasma membrane enzyme 
5’.nucleotidase. This model is of interest for studying 
the glucocorticoid receptor and steroid structure- 
activity relationships, as well as the hormonal control 
of membrane enzymes and biogenesis, in the human 
species. 
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